BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 34022414)

  • 1. Molecular Peritoneal Staging for Pancreatic Ductal Adenocarcinoma Using Mutant KRAS Droplet-Digital Polymerase Chain Reaction: Results of a Prospective Clinical Trial.
    Yonkus JA; Alva-Ruiz R; Abdelrahman AM; Leiting JL; Schneider AR; Grotz TE; Cleary SP; Smoot RL; Nagorney DM; Kendrick ML; Kipp BR; Truty MJ
    J Am Coll Surg; 2021 Jul; 233(1):73-80.e1. PubMed ID: 34022414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peritoneal Cell-Free Tumor DNA is a Biomarker of Locoregional and Peritoneal Recurrence in Resected Pancreatic Ductal Adenocarcinomas.
    Leick KM; Tomanek-Chalkley A; Coleman KL; Chan CHF
    Ann Surg Oncol; 2023 Oct; 30(11):6652-6660. PubMed ID: 37303025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peritoneal Lavage Tumor DNA as a Novel Biomarker for Predicting Peritoneal Recurrence in Pancreatic Ductal Adenocarcinoma.
    Suenaga M; Fujii T; Yamada S; Hayashi M; Shinjo K; Takami H; Niwa Y; Sonohara F; Shimizu D; Kanda M; Kobayashi D; Tanaka C; Nakayama G; Koike M; Fujiwara M; Kondo Y; Kodera Y
    Ann Surg Oncol; 2021 Apr; 28(4):2277-2286. PubMed ID: 32875467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic impact of RT-PCR-based detection of peritoneal micrometastases in patients with pancreatic cancer undergoing curative resection.
    Kelly KJ; Wong J; Gladdy R; Moore-Dalal K; Woo Y; Gonen M; Brennan M; Allen P; Fong Y; Coit D
    Ann Surg Oncol; 2009 Dec; 16(12):3333-9. PubMed ID: 19763694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Yield of Staging Laparoscopy for Pancreatic Cancer in the Modern Era: Analysis of More than 1,000 Consecutive Patients.
    Gudmundsdottir H; Yonkus JA; Alva-Ruiz R; Kendrick ML; Smoot RL; Warner SG; Starlinger P; Thiels CA; Nagorney DM; Cleary SP; Grotz TE; Truty MJ
    J Am Coll Surg; 2023 Jul; 237(1):49-57. PubMed ID: 37026837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High prevalence of mutant KRAS in circulating exosome-derived DNA from early-stage pancreatic cancer patients.
    Allenson K; Castillo J; San Lucas FA; Scelo G; Kim DU; Bernard V; Davis G; Kumar T; Katz M; Overman MJ; Foretova L; Fabianova E; Holcatova I; Janout V; Meric-Bernstam F; Gascoyne P; Wistuba I; Varadhachary G; Brennan P; Hanash S; Li D; Maitra A; Alvarez H
    Ann Oncol; 2017 Apr; 28(4):741-747. PubMed ID: 28104621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subclinical cancer cell dissemination in peritoneal lavage fluid detected by reverse-transcription polymerase chain reaction identifies patients at high risk for peritoneal recurrence and consequent impaired survival in the setting of preoperative chemoradiation therapy for pancreatic cancer.
    Takahashi H; Akita H; Wada H; Tomokuni A; Asukai K; Takahashi Y; Yanagimoto Y; Matsunaga T; Sugimura K; Yamamoto K; Nishimura J; Yasui M; Omori T; Miyata H; Yamamoto T; Nakanishi M; Shirayanagi M; Yamasaki T; Ohue M; Yano M; Sakon M; Ishikawa O
    Surgery; 2018 Dec; 164(6):1168-1177. PubMed ID: 30146098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of intraoperative peritoneal washing cytology for patients with potentially resectable pancreatic ductal adenocarcinoma.
    Hoshimoto S; Hishinuma S; Shirakawa H; Tomikawa M; Ozawa I; Hoshi N; Hoshi S; Hirabayashi K; Ogata Y
    Pancreatology; 2017; 17(1):109-114. PubMed ID: 27840175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Implications of Multiplex Detection of
    Kim MK; Woo SM; Park B; Yoon KA; Kim YH; Joo J; Lee WJ; Han SS; Park SJ; Kong SY
    Clin Chem; 2018 Apr; 64(4):726-734. PubMed ID: 29352043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perioperative cancer cell dissemination detected with a real-time RT-PCR assay for EpCAM is not associated with worse prognosis in pancreatic ductal adenocarcinoma.
    Sergeant G; Roskams T; van Pelt J; Houtmeyers F; Aerts R; Topal B
    BMC Cancer; 2011 Jan; 11():47. PubMed ID: 21281486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laparoscopy and peritoneal cytology in the staging of pancreatic cancer.
    Jimenez RE; Warshaw AL; Fernandez-Del Castillo C
    J Hepatobiliary Pancreat Surg; 2000; 7(1):15-20. PubMed ID: 10982586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutant
    Perets R; Greenberg O; Shentzer T; Semenisty V; Epelbaum R; Bick T; Sarji S; Ben-Izhak O; Sabo E; Hershkovitz D
    Oncologist; 2018 May; 23(5):566-572. PubMed ID: 29371474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KRAS mutation allele frequency threshold alters prognosis in right-sided resected pancreatic cancer.
    Nauheim D; Moskal D; Renslo B; Chadwick M; Jiang W; Yeo CJ; Nevler A; Bowne W; Lavu H
    J Surg Oncol; 2022 Aug; 126(2):314-321. PubMed ID: 35333412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-194-5p in Pancreatic Ductal Adenocarcinoma Peritoneal Washings is Associated with Peritoneal Recurrence and Overall Survival in Peritoneal Cytology-Negative Patients.
    Kubo H; Hiroshima Y; Mori R; Saigusa Y; Murakami T; Yabushita Y; Sawada Y; Homma Y; Kumamoto T; Matsuyama R; Endo I
    Ann Surg Oncol; 2019 Dec; 26(13):4506-4514. PubMed ID: 31489551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KRAS mutations in pancreatic circulating tumor cells: a pilot study.
    Kulemann B; Liss AS; Warshaw AL; Seifert S; Bronsert P; Glatz T; Pitman MB; Hoeppner J
    Tumour Biol; 2016 Jun; 37(6):7547-54. PubMed ID: 26684803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-593-3p Expression in Peritoneal Lavage Fluid as a Prognostic Marker for Pancreatic Cancer Patients Undergoing Staging Laparoscopy.
    Hata T; Mizuma M; Masuda K; Chiba K; Ishida M; Ohtsuka H; Nakagawa K; Morikawa T; Kamei T; Unno M
    Ann Surg Oncol; 2021 Apr; 28(4):2235-2245. PubMed ID: 33393045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The incremental benefit of two quadrant lavage for peritoneal cytology at staging laparoscopy for oesophagogastric adenocarcinoma.
    Munasinghe A; Kazi W; Taniere P; Hallissey MT; Alderson D; Tucker O
    Surg Endosc; 2013 Nov; 27(11):4049-53. PubMed ID: 23836122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Percutaneous Peritoneal Lavage for the Rapid Staging of Gastric and Pancreatic Cancer.
    Pak LM; Coit DG; Eaton AA; Allen PJ; D'Angelica MI; DeMatteo RP; Jarnagin WR; Strong VE; Kingham TP
    Ann Surg Oncol; 2017 May; 24(5):1174-1179. PubMed ID: 28058561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for latent distant organ metastasis detected by staging laparoscopy in patients with radiologically defined locally advanced pancreatic ductal adenocarcinoma.
    Karabicak I; Satoi S; Yanagimoto H; Yamamoto T; Hirooka S; Yamaki S; Kosaka H; Inoue K; Matsui Y; Kon M
    J Hepatobiliary Pancreat Sci; 2016 Dec; 23(12):750-755. PubMed ID: 27794194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peritoneal exfoliative cytology and Ki-ras mutational analysis in patients with pancreatic adenocarcinoma.
    Rall CJ; Rivera JA; Centeno BA; Fernandez-del Castillo C; Rattner DW; Warshaw AL; Rustgi AK
    Cancer Lett; 1995 Nov; 97(2):203-11. PubMed ID: 7497464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.